Trials / Completed
CompletedNCT06180070
Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol)
Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol) in Healthy Subjects Under Fasting Condition
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Humanis Saglık Anonim Sirketi · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Ibuprofen/ Paracetamol tablets (200mg Ibuprofen/ 500mg Paracetamol) versus Nuromol® tablets (200mg Ibuprofen/ 500mg Paracetamol) in healthy subjects under fasting condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ibuprofen/ Paracetamol tablets | 1 tablet of 200mg Ibuprofen/ 500mg Paracetamol |
| DRUG | Nuromol® tablets | 1 tablet of 200mg Ibuprofen/ 500mg Paracetamol |
Timeline
- Start date
- 2023-08-29
- Primary completion
- 2023-09-14
- Completion
- 2023-10-16
- First posted
- 2023-12-22
- Last updated
- 2023-12-22
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT06180070. Inclusion in this directory is not an endorsement.